Professor Albert Ludolph
Professor of Neurology and Chairman of the Department of Neurology at the University Hospital and Medical Faculty of Ulm. He is also acting Director of the Academic Neuroscience Centre of the [...]
Second patent filed for novel orexin 1 antagonist programme
A second patent application for novel orexin 1 antagonists has been filed on 25 October 2017. This is an entirely new composition of matter patent supporting our binge eating disorder and alcohol [...]
Chronos Senior Mangement interviewed at The Telegraph studios
Chronos CEO, CSO and VP Corporate Development were interviewed at The Telegraph studios recently. Click here to see the interview on our approach to degenerative and behavioural brain disease.
Professor Kevin Talbot MB BS, DPhil, FRCP
Kevin Talbot qualified in medicine (MB BS) with Distinction from the University of London and trained in Neurology in London and Oxford. He joined the laboratory of Professor Kay Davies in 1995 [...]
Professor Ammar Al-Chalabi MB ChB, PhD, FRCP
Amar graduated from Leicester University Medical School in 1989 and came to King’s in 1994 as a clinician scientist working with Professor Nigel Leigh, studying genetic risk factors in motor [...]
Professor Merit Cudkowicz M.D. MSc. Harvard Medical School; Director, Mass. Gen. ALS Clinic.
Dr. Merit Cudkowicz is the Julianne Dorn Professor of Neurology at Massachusetts General Hospital, at Harvard Medical School. Dr. Cudkowicz completed medical training at the Health Science and [...]
